MARLENE DEBEL - 27 Feb 2024 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP & Chief Risk Officer
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
27 Feb 2024
Net transactions value
-$1,120,807
Form type
4
Filing time
29 Feb 2024, 16:21:01 UTC
Previous filing
26 Feb 2024
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award +5,965 +7% 91,497 27 Feb 2024 Direct F1
transaction MET Common Stock Award +35,957 +39% 127,454 27 Feb 2024 Direct F2
transaction MET Common Stock Tax liability $1,120,807 -16,206 -13% $69.16 111,248 27 Feb 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Award $0 +17,896 $0.000000 17,896 27 Feb 2024 Common Stock 17,896 $69.16 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2 Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F3 Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F4 The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.